Go back
Rules And Guidance For Pharmaceutical Manufacturers And Distributors 2017 Orange Guide(10th Edition)
Authors:
Medicines & Healthcare Products Regulatory Agency
Cover Type:Hardcover
Condition:Used
In Stock
Shipment time
Expected shipping within 2 DaysPopular items with books
Access to 30 Million+ solutions
Free ✝
Ask 50 Questions from expert
AI-Powered Answers
✝ 7 days-trial
Total Price:
$0
List Price: $23.03
Savings: $23.03(100%)
Solution Manual Includes
Access to 30 Million+ solutions
Ask 50 Questions from expert
AI-Powered Answers
24/7 Tutor Help
Detailed solutions for Rules And Guidance For Pharmaceutical Manufacturers And Distributors 2017 Orange Guide
Price:
$9.99
/month
Book details
ISBN: 0857112856, 978-0857112859
Book publisher: Pharmaceutical Press
Get your hands on the best-selling book Rules And Guidance For Pharmaceutical Manufacturers And Distributors 2017 Orange Guide 10th Edition for free. Feed your curiosity and let your imagination soar with the best stories coming out to you without hefty price tags. Browse SolutionInn to discover a treasure trove of fiction and non-fiction books where every page leads the reader to an undiscovered world. Start your literary adventure right away and also enjoy free shipping of these complimentary books to your door.
Book Summary: Familiarly known as the Orange Guide, this title is an essential reference work for all those involved in the manufacture and distribution of medicines in Europe. It is compiled by the UK drug regulatory body, MHRA, and brings together the European and UK guidance documents and information on legislation relating to the manufacture and distribution of medicines for human use. It contains EU guidance on good manufacturing and good distribution practice along with relevant information on EU and UK legislation. Changes in this new edition:Revised Annex 15. The revision of Annex 15 takes into account changes to other sections of the EudraLex, Volume 4, Part I, relationship to Part II, Annex 11, ICH Q8, Q9, Q10 and Q11, QWP guidance on process validation, and changes in manufacturing technology.Revised Annex 16. The GMP Guide Annex 16 has been revised to reflect the globalisation of the pharmaceutical supply chains and the introduction of new quality control strategies. The revision has been carried out in the light of Directive 2011/62/EU amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of falsified medicinal products. This version also implements ICH Q8, Q9 and Q10 documents, and interpretation documents, such as the manufacturing and importation authorisation (MIA) interpretation document, as applicable. Also, some areas, where the interpretation by Member States has not been consistent, have been clarified. This revised Annex came into operation 15 April 2016.The introduction of guidelines on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities.The introduction of guidelines on the formalised risk assessment for ascertaining the appropriate GMP for excipients.The addition of the Guidelines on principles of Good Distribution Practice of active substances for medicinal products for human use (2015/C 95/01).These guidelines provide stand-alone guidance on Good Distribution Practice (GDP) for manufacturers, importers and distributors of active substances for medicinal products for human use. These guidelines should be followed as of 21 September 2015.The addition of the principles and guidelines of Good Manufacturing Practice (GMP) for active substances for medicinal products for human use, including active substances intended for export.Revisions to the UK Human Medicines Regulations 2012.MHRA GMP Data Integrity Definitions and Guidance for Industry is now included which sets out MHRA expectations for data integrity in good manufacturing practice (GMP). The Guidance complements existing EU GMP guidance and should be read in conjunction with national medicines legislation and the GMP standards published in Eudralex volume.
Customers also bought these books
Diagnostics Reimbursement Compass A 90 Minute Guide To Define Demonstrate And Capture Diagnostics Value Confidently - 1st Edition
Norbert Farkas
ISBN: B08WP5GX37, 979-8709711327
$0 $6.73Frequently Bought Together
Skip The Flip Three Keys To Any Deal - 1st Edition
Hayden Crabtree
ISBN: 1734768622, 978-1734768626
$0 $24.88
Economic Liberalisation Social Capital And Islamic Welfare Provision - 2009th Edition
J Harrigan
ISBN: 0230202195, 978-0230202191
$0 $45.50
Essentials Of Business Statistics Communicating With Numbers - 1st Edition
Sanjiv Jaggia
ISBN: 78020549, 978-0078020544
$0 $9.00
Logistics And Supply Chain Innovation A Practical Guide To Disruptive Technologies And New Business Models - 2nd Edition
John Manners-Bell
ISBN: 1398607487,1398607495
$0 $138.61
Annual Editions Anthropology - 40th Edition
Elvio Angeloni
ISBN: 1259666417, 978-1259666414
$0 $39.99
Measurement Of Facilities Management Performance In Ghanas Public Hospitals - 1st Edition
Daniel Amos
ISBN: 9813343346, 978-9813343344
$0 $109.99
Top Reviews for Books
Mohamed sami
( 4 )
"Delivery was considerably fast, and the book I received was in a good condition."